In this scenario, RNA sequencing and functional enrichment analysis performed in primary murine breast tumors revealed that FAK inhibition reduces the expression of genes involved in the cell cycle progression and tumor cell proliferation [72]. The gene discussed is PTK2; the disease is breast neoplasm.